TKPHF

Takeda Pharmaceutical Company

Exchange: PINK

Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, marketing, sale, and import/export of pharmaceutical drugs worldwide. It provides products in various therapeutic areas, including cardiovascular and metabolic, respiratory and immunology, oncology, central nervous system, general medicine, vaccines, and consumer healthcare drugs and quasi-drugs. The company has strategic partnership with BioMotiv, LLC; and a collaboration agreement with Mersana Therapeutics Inc. and Queen Mary University of London. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Osaka, Japan.

Current Price

$32.26

+0.00%

Profile

Valuation (TTM)

Market Cap—

P/E—

EV—

P/B—

Shares Out—

P/Sales—

Revenue—

EV/EBITDA—

Takeda Pharmaceutical Company (TKPHF) Financial Statements

TKPHF Financial Data

EBITDA—

Revenue (TTM)—

Gross Profit (TTM)—

Gross Margin—

Operating Margin—

ROE—

ROA—

Debt/Equity—

Current Ratio—

FCF—

FCF Yield—

Piotroski F-Score—

Rev/Share (TTM)—

50-Day MA$34.01

200-Day MA$31.09

Shares Outstanding—

TKPHF Computed Insights

FCF—

FCF Growth Rate—

EPS Growth (CAGR)—

WACC10.00%

Income Statement

Balance Sheet

Cash Flow Statement

TKPHF Financial Statements & Data

Takeda Pharmaceutical Company (TKPHF) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Takeda Pharmaceutical Company's financial performance and position.

Weighted average cost of capital (WACC) is 10.00%.

GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.

Use Takeda Pharmaceutical Company's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.